
Luna Kaduri
Cancer Treatment
31+
Years of Experience
About Luna Kaduri
<h3 style="margin-left:0px;"><strong>RESEARCH ACTIVITY</strong></h3><p style="margin-left:0px;"><strong>1998–2000</strong> — Conducted research on the <strong>genesis of cancer</strong> at <strong>The Royal Marsden Hospital</strong> (England).</p><h3 style="margin-left:0px;"><strong>PUBLICATIONS</strong></h3><p style="margin-left:0px;">Authored numerous peer-reviewed articles in scientific journals. Selected topics include:</p><p style="margin-left:0px;"><strong>Oncotype Dx Recurrence Score</strong> in <strong>BRCA1/2 germline mutation carriers</strong> with hormone receptor-positive breast cancer.</p><p style="margin-left:0px;"><strong>TP53 missense mutation recurrence</strong> in cancer patients of Arab descent.</p><p style="margin-left:0px;"><strong>Adjuvant autologous vaccine</strong> for stage III microscopic melanoma: biomarker survival and enhanced response to <strong>CTLA-4 blockade</strong>.</p><p style="margin-left:0px;">Prognostic significance of <strong>(R)CA15-3 assay</strong> in primary breast cancer.</p><p style="margin-left:0px;">Diagnostic and prognostic value of <strong>comparative thymidine kinase 1 (TK1) activity assays</strong> in breast cancer patient serum.</p><p style="margin-left:0px;">Complete remission in a <strong>BRCA2 mutation carrier</strong> with metastatic pancreatic adenocarcinoma treated with <strong>cisplatin</strong>.</p><p style="margin-left:0px;"><strong>Autologous vaccine-induced antitumor and self-reactive immune responses</strong> in melanoma: impact on patient survival and dependence on <strong>MHC class II expression</strong>.</p><h3 style="margin-left:0px;"><strong>PROFESSIONAL AFFILIATIONS</strong></h3><p style="margin-left:0px;"><strong>Israeli Society of Clinical Oncology</strong></p><p style="margin-left:0px;"><strong>Israel Medical Association</strong></p><h3 style="margin-left:0px;"><strong>AWARDS & GRANTS</strong></h3><p style="margin-left:0px;"><strong>Cancer Genetics Research Foundation Award</strong></p><p style="margin-left:0px;"><strong>Landau Prize</strong></p><p style="margin-left:0px;"><strong>Judith Segal Memorial Award</strong></p>
Good to know
Speciality
• Cancer Treatment
Language Spoken
• English• Hebrew
Awards
- • 1997 – Landau Prize for Excellence in Cancer Research
- • 2001 – Judith Segal Award for Achievements in Cancer Research
- • Judith Segal Memorial Award
- • Cancer Genetics Research Foundation Award
- • Israeli Society of Clinical Oncology
- • International Society of Clinical Oncology
- • Israel Medical Association
Clinical oncologist
1990–1991 – Medical Intern – Hadassah University Hospital, Israel
1992–1997 – Resident in Oncology – Hadassah University Hospital, Israel
1997–Present – Senior Oncologist – Hadassah University Hospital, Israel
1998–2000 – Researcher in Cancer Genesis – The Royal Marsden Hospital, England
2000–Present – Head of the Oncogenetics Unit – Hadassah Medical Center, Israel
All Procedures
Performed by Luna Kaduri
All Procedures Performed by Luna Kaduri
CureMeAbroadIs Absolutely Free
Just discovery so you can choose what's right for you!


World's No. 1 Medical Discovery Platform

